These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 20072878)

  • 1. Remote loading of anthracyclines into liposomes.
    Lewrick F; Süss R
    Methods Mol Biol; 2010; 605():139-45. PubMed ID: 20072878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?
    Theodoulou M; Hudis C
    Cancer; 2004 May; 100(10):2052-63. PubMed ID: 15139046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal doxorubicin.
    Tardi PG; Boman NL; Cullis PR
    J Drug Target; 1996; 4(3):129-40. PubMed ID: 8959485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC; Liu XY; Lü WL; Lee HS; Goh BC; Zhang Q
    Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac safety of liposomal anthracyclines.
    Batist G
    Cardiovasc Toxicol; 2007; 7(2):72-4. PubMed ID: 17652807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
    Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
    J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD19-targeted liposomal doxorubicin improves the therapeutic efficacy in murine B-cell lymphoma and ameliorates the toxicity of liposomes with varying drug release rates.
    Allen TM; Mumbengegwi DR; Charrois GJ
    Clin Cancer Res; 2005 May; 11(9):3567-73. PubMed ID: 15867261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The encapsulation of idarubicin within liposomes using the novel EDTA ion gradient method ensures improved drug retention in vitro and in vivo.
    Gubernator J; Chwastek G; Korycińska M; Stasiuk M; Grynkiewicz G; Lewrick F; Süss R; Kozubek A
    J Control Release; 2010 Aug; 146(1):68-75. PubMed ID: 20510316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversal of multidrug resistance by transferrin-conjugated liposomes co-encapsulating doxorubicin and verapamil.
    Wu J; Lu Y; Lee A; Pan X; Yang X; Zhao X; Lee RJ
    J Pharm Pharm Sci; 2007; 10(3):350-7. PubMed ID: 17727798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
    Parr MJ; Masin D; Cullis PR; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1319-27. PubMed ID: 9067319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases.
    Haran G; Cohen R; Bar LK; Barenholz Y
    Biochim Biophys Acta; 1993 Sep; 1151(2):201-15. PubMed ID: 8373796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
    Chiu GN; Abraham SA; Ickenstein LM; Ng R; Karlsson G; Edwards K; Wasan EK; Bally MB
    J Control Release; 2005 May; 104(2):271-88. PubMed ID: 15907579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
    Mayer LD; Dougherty G; Harasym TO; Bally MB
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1406-14. PubMed ID: 9067330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques.
    Mayer LD; St-Onge G
    Anal Biochem; 1995 Dec; 232(2):149-57. PubMed ID: 8747469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal anthracyclines.
    Gabizon AA
    Hematol Oncol Clin North Am; 1994 Apr; 8(2):431-50. PubMed ID: 8040147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposomal anthracyclines for breast cancer.
    Sparano JA; Winer EP
    Semin Oncol; 2001 Aug; 28(4 Suppl 12):32-40. PubMed ID: 11552228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection.
    Ishida T; Atobe K; Wang X; Kiwada H
    J Control Release; 2006 Oct; 115(3):251-8. PubMed ID: 17045355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.